Skip to main content
logo
Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
5.39
+0.39 (7.80%)
At close: Aug 12, 2026, 4:00 PM EDT
5.44
+0.05 (0.93%)
After-hours: Aug 12, 2026, 6:21 PM EDT

Unicycive Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
14813010330831
Market Cap Growth
185.58%26.79%240.57%266.77%-73.38%-
Enterprise Value
86.8989.1177.2821.267.9314.62
Last Close Price
5.395.777.948.685.4020.60

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-1.67----
PS Ratio
---44.698.65-
PB Ratio
3.354.3113.83-7.92-17.651.87
P/TBV Ratio
2.293.047.16--1.46

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
---31.498.33-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.0000.02-0.1200.01
Net Debt / Equity Ratio
-1.14-1.36-3.432.340.64-0.99
Net Debt / EBITDA Ratio
1.871.420.800.440.021.82
Net Debt / FCF Ratio
2.181.310.890.490.022.81
Asset Turnover
-000.080.090
Quick Ratio
3.282.181.080.550.147.88
Current Ratio
3.812.591.280.760.818.75
Return on Equity (ROE)
-84.40%-141.15%-2028.11%1428.96%-225.47%-145.04%
Return on Assets (ROA)
-54.71%-73.06%-140.07%-244.27%-167.44%-94.75%
Return on Invested Capital (ROIC)
-4101.86%-3748.19%-2673.08%-2869.34%-4440.84%-598.87%
Return on Capital Employed (ROCE)
-79.36%-156.40%-1527.56%1090.78%-223.24%-128.54%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-107.81%-137.17%-172.97%-62.98%-28.96%-37.37%
Total Shareholder Return
-107.81%-137.17%-172.97%-62.98%-28.96%-37.37%
SEC Filings: 10-K · 10-Q